Several small-cap biotech and healthcare names posted notable gains in Thursday's after-hours trading session, with investors reacting to recent corporate updates and clinical milestones. Inspira Technologies Oxy B.H.N. Ltd. (IINN) rose 5.88% to $1.08 as of 7:56 PM EST. While there was no fresh news...
Inspira Technologies Oxy B.H.N. Ltd. (IINN), Tuesday announced that the company has announced positive results from the clinical study of its AI-powered HYLA blood sensor, which is designed to monitor blood parameters. During the study, the HYLA achieved 96 percent accuracy for a key parameter, as...
Inspira Technologies Oxy B.H.N. Ltd. (IINN) announced on Friday that it has received a second U.S. patent for its VORTX orbiting blood oxygenation delivery system, which is a key component of the INSPIRA ART device. This approval increases the total number of innovative claims for this core technology...
Israeli medical technology company Inspira Technologies OXY B.H.N. Ltd. (IINN) announced Thursday the receipt of the Israeli Ministry of Health's medical devices and accessories (AMAR) approval for the INSPIRA ART100, an Extra-Corporeal Membrane Oxygenation and Cardiopulmonary Bypass system. This...
Inspira Technologies Oxy B.H.N. Ltd. (IINN), Tuesday announced that the company's cardiopulmonary bypass system, ART100, has received 510(k) clearance from the U.S. Food and Drugs Administration. The medical technology company said that the device is intended for use in an extracorporeal perfusion...
August 13, 2026 05:33 ET The World Health Organization’s cancer research agency, the International Agency for Research on Cancer (IARC), has classified three widely used medicines as carcinogenic to humans.